Embolotherapy Global Market is estimated to be worth $6,115.9 million by 2029

IQ4I Research & Consultancy published a new report on “Embolotherapy Global Market – Forecast To 2029” 


The Embolotherapy global market report covers four segments namely product, application, procedures, end-user, and geography. These segments are further segmented as follows:

  1. Embolotherapy Global Market, Based on Product
  • Temporary agents
  • Autologous agents
  • Resorbable gelatin sponge
  • Permanent Agents
  • Particle agents
    • Poly Vinyl Alcohol (PVA)
    • Microspheres
  • Coils
    • Pushable coils
    • Detachable Coils
  • Liquid Embolization Agents
  • Flow Diverters & Flow Disruptors
  • Others
    1. Embolotherapy Global Market, Based on Application
  • Neurology
  • Intracranial aneurysm
  • Arteriovenous malformation
  • Oncology
  • Liver Cancer
  • Lung Cancer
  • Others
  • Peripheral Vascular Diseases
  • Urology
  • Others
    1. Embolotherapy Global Market, Based on Procedures
  • Transcatheter Arterial Embolization (TAE)
  • Transcatheter Arterial Chemoembolization (TACE)
  • Drug Eluting Beads TACE (DEB-TACE)
  • conventional transarterial chemo-embolization (cTACE)
  • Transcatheter Arterial Radioembolization (TARE)/ Selective Internal Radiation Therapy (SIRT)
    1. Embolotherapy Global Markets, Based on End-user
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
    1. Embolotherapy Global Market, Based on Geography
  • North America (U.S. and Rest of NA)
  • Europe (Germany, France, Italy, and the Rest of Europe)
  • Asia-Pacific (Japan, China, India, and Rest of APAC)
  • Rest of the World (Brazil, the Rest of South America, and the Middle East & Africa)

Each segment of this report offers market values for its sub-segments and geographies as well. It also provides market dynamics with respect to drivers, restraints, opportunities and performance of major key players.

According to IQ4I analysis, the Embolotherapy global market is expected to grow at mid single digit CAGR from 2022 to 2029 to reach $6,115.9 million by 2029. Factors such as the growing patient population with chronic conditions increasing the demand for embolization procedures, and technology advancements are driving the market growth, whereas, acquisitions and collaborations and emerging markets are providing growth opportunities. On the other hand, side effects, complications, and risks associated with embolization and lack of skilled and trained professionals are restraining the market growth, while increasing product recalls, competition from alternative therapies and stringent regulatory requirements for product development and approvals are threatening the market growth.

The report covers business intelligence information of the Embolotherapy market segments based on products, applications, procedures, end-users, and geography. Market share analysis of the overall embolotherapy market, coils, flow diverters & disruptors, and radioembolization market. Analysis of the opportunities for stakeholders by identifying procedural volume (based on epidemiological data, average selling price (ASP)), and the high-growth segments of the market. Global procedure volume for intracranial aneurysm and interventional oncology embolization, analysis of the number of units per procedure, average selling price, and the number of units sold (neurovascular coils). Revenue forecast of the Profiles of major players in Embolotherapy with details of their product offerings, business strategies, and SWOTs.

Major players in the embolotherapy market include Medtronic, PLC (Ireland), Microport Scientific (China), Boston Scientific Corporation (U.S.), Stryker (U.S.), Terumo Corporation (Japan), Penumbra, Inc. (U.S.), Sirtex (CDH) (China), Johnson & Johnson (U.S.), Balt Group (France), Kaneka Corporation (Japan), Merit Medical (U.S.), Cook Medical (U.S.), Siemens Healthineers (Varian) (Germany), and Guerbet (France).